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ABSTRACT
Healthy aging is typified by a progressive and absolute loss of podocytes over the lifespan of animals and
humans. To test the hypothesis that a subset of glomerular parietal epithelial cell (PEC) progenitors transition
to a podocyte fate with aging, dual reporter PEC-rtTA|LC1|tdTomato|Nphs1-FLPo|FRT-EGFP mice were
generated. PECs were inducibly labeled with a tdTomato reporter, and podocytes were constitutively labeled
with an EGFP reporter. With advancing age (14 and 24 months) glomeruli in the juxta-medullary cortex (JMC)
were more severely injured than those in the outer cortex (OC). In aged mice (24m), injured glomeruli with
lower podocyte number (41% decrease), showed more PEC migration and differentiation to a podocyte fate
than mildly injured or healthy glomeruli. PECs differentiated to a podocyte fate had ultrastructural features of
podocytes and co-expressed the podocyte markers podocin, nephrin, p57 and VEGF164, but not markers of
mesangial (Perlecan) or endothelial (ERG) cells. PECs differentiated to a podocyte fate did not express CD44, a
marker of PEC activation. Taken together, we demonstrate that a subpopulation of PECs differentiate to a
podocyte fate predominantly in injured glomeruli in mice of advanced age.

INTRODUCTION
Glomerular podocytes are terminally differentiated
epithelial cells that cannot proliferate, and are therefore
unable to self-renew [1, 2] Thus, in states of loss such
as healthy aging [3–5] and glomerular diseases [6–8]
any podocyte replacement must rely on local
progenitor/stem cells [9]. Despite evidence that
podocytes can be partially or even fully replaced
focally, in individual glomeruli in which they have been
depleted [10–15], some dispute this notion [16–18].
These differing views might in part be due to the
interpretation of results, a focus on density rather than
absolute number of new podocytes, the belief that
kidney function must be completely restored to prove
that even partial replacement in individual glomeruli
occurs, and changes in cell type markers that are not
always reliable.
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Because of the challenges of studying podocyte
replacement in humans, studies have largely relied on
lessons learned from animal models. This too has
contributed to the “podocyte regeneration/replacement
debate”. For instance, studies characterized by
glomerular hypertrophy that leads to reduced podocyte
density without a loss of podocytes themselves should
be questioned as a proper model to study podocyte
regeneration. Similarly, factors such as mouse age,
strain, sex, and the duration of the studies, are potential
confounders in this debate. Additionally, the norm is to
examine outer cortical glomeruli, but in many instances
the juxta-medullary glomeruli are not examined, yet
have more pronounced injury [19]. Healthy aging is
typified by a progressive and absolute loss of podocytes
over the lifespan of animals [18, 20] and humans [21].
Podocyte density is also lowered with advancing age
due to both a decrease in absolute number, and a
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concomitant increase in the size of the glomerulus
secondary to aging associated hypertrophy [22]. The
age of a mouse is critical in the definition of aging
(https://www.nia.nih.gov/research/dab/aged-rodentcolonies-handbook/strain-survival-information). For
example, mouse ages 12, 18, and 24 months correspond
to human ages 42.5, 56 and 69 years old respectively
[23] and therefore using mice aged 17 months and
younger is not considered a model of aging.
Currently, glomerular parietal epithelial cells (PECs)
[10–12, 24] and cells of renin lineage [13, 25–28] have
been shown to acquire many podocyte-like features in
experimental models of podocyte depletion. However,
we have shown that both sources of podocyte progenitors
are adversely impacted by advancing age. For example,
their numbers decrease with age leading to a reduced
reservoir available to perform progenitor functions [19,
29], they lose some of their characteristic markers,
acquire phenotypic changes [19, 30], and their expected
responses to stimuli are reduced, such as the response of
cells of renin lineage to RAAS blockade [31].
Damage to glomeruli is focally distributed in the aged
kidney (defined as less than 50% of all glomeruli),
rather being a diffuse phenomenon. Moreover, changes
differ in glomeruli of the kidney outer cortex versus the
glomeruli of the juxta-medullary region [19]. In order to
better understand podocyte replacement within
individual glomeruli in healthy middle and advanced
aged mice in the context of PEC progenitors, we studied
a dual PEC – Podocyte (PEC-PODO) reporter mouse
[24] to genetically lineage trace any podocyte
replacement from a PEC progenitor source.

RESULTS
Glomerular injury is limited to those outer cortical
(OC) and juxta-medullary cortical (JMC) glomeruli
with reduced podocyte number in aged dual
reporter mice
Because changes in glomeruli in the aging mouse
kidney are focal (less than 50% of glomeruli affected),
we began by quantitating the degree of damage to
individual OC and JMC glomeruli, graded on a score of
0-3 (Figure 1). Silver staining was used to validate the
PAS (Supplementary Figure 1). To correlate glomerular
injury with podocyte number in individual glomeruli,
the number of p57 stained cells per glomerular cross
section was also quantitated in each individual
glomerulus in which the injury score was recorded
(Figure 1). As expected, the overwhelming majority of
OC and JMC glomeruli in young mice (6 months) had a
injury score of zero, 95.0±3.7% and 93.8±4.7% in OC
and JMC respectively (Figure 1A, 1B, 1G, 1H).
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Interestingly, podocyte number was lower in the
occasional glomerulus with a score of 1 in both OC and
JMC glomeruli in young mice.
In middle aged mice (14 months), 70.0±7.8% OC and
63.3±10.5% JMC glomeruli had injury scores of zero
(Figure 1G, 1H). The remaining glomeruli had scores of
1 (26.0±7.8%), 2 (3.6±1.2%), and 3 (1.2±1.2%) in OC
glomeruli (Figure 1C, 1G), and scores of 1 (30.4±8.2), 2
(5.9±1.6%), and 3 (1.3±1.0%) in JMC glomeruli (Figure
1D, 1H). Podocyte number per glomerular cross section
was progressively lower with increasing injury scores in
both OC and JMC glomeruli (Figures 1I, 1J).
In aged mice (24 months), the percentage of normal
glomeruli (score=0) decreased to 53.1±4.7% and
44.9±12.6% in the OC and JMC respectively (Figures
1E–1H). The remaining aged OC glomeruli had scores
of 1 (31.6±7.2%), 2 (12.5±5.2%) and 3 (2.4±2%), and
the remaining aged JMC glomeruli had scores of 1
(37.3±12.4%), 2 (13.7±5.9%) and 3 (3.9±
3.2%). Podocyte number per glomerular cross section
was progressively lower in both aged OC and
JMC glomeruli with each increase in injury score
(Figures 1I, 1G).
Genetic confirmation that a small fraction of labeled
PECs differentiate to a podocyte fate in glomeruli
with reduced podocyte number
The transgenic mice used were designed to visualize
permanently undifferentiated PECs (red), native
podocytes (green) and new podocytes that derived from
a PEC fate (yellow). Autofluorescence of these
reporters avoided the need for antibodies for
visualization (Figure 2). Although absent in young mice
(Figure 2A, 2D), a subset of red PECs were visualized
in the glomerular tuft in middle-aged and aged mice
(Figure 2B, 2C, 2E, 2F), consistent with migration
from Bowman’s capsule. Yellow cells were also
detected in the glomerular tuft predominantly in aged
mice (Figure 2C, 2F), consistent with differentiation to
a podocyte fate.
In order to quantitate the number of undifferentiated
labeled PECs (red color) and PECs that differentiated to
a podocyte fate (yellow color) in the glomerular tuft,
and correlate this with the number of podocytes in the
same individual glomerular cross sections in the OC,
and in the JMC, staining for p57 and PAS were
performed on the same slides in which red, green and
yellow fluorescence were observed (Supplementary
Figure 2).
For each individual glomerulus, the number of
tdTomato+ (red) or tdTomato+/EGFP+ (yellow) cells per

AGING

glomerular cross section were plotted against the p57+
cell count (used as a podocyte marker) in that same
glomerulus. The trend that emerges shows the
prerequisite of podocyte loss, and significant podocyte
loss, in order for migration and subsequent
differentiation to occur (Figure 3). In this particular
case, when the number of p57+ cells per glomerular
cross section drops below 10, red PECs begin to migrate

onto the glomerular tuft. In individual glomeruli in
which the number of p57+ cells drop to below 7, a
subset of PECs differentiate to a podocyte-like fate (de
novo express EGFP and become yellow). In the
glomeruli with podocyte loss that was great enough to
warrant migration (red cells on the tuft), 42.0% of those
glomeruli experienced differentiation to a podocyte-like
fate as defined by the presence of a yellow cell.

Figure 1. Glomerulosclerosis in aged PEC-PODO reporter mice. (A–F) Representative images of p57 stained (brown, nuclear)
podocytes with periodic acid–Schiff staining (PAS) counterstaining from young (6 months) (A, B), middle age (14 months) (C, D) and aged (24
months) (E, F) mice. Glomeruli were divided into two compartments: outer cortex (OC) (A, C, E) and juxta-medullary cortex (JMC) (B, D, F).
Small insets represent examples of OC glomeruli (E1–E4) and JMC glomeruli (F1–F4) for each scoring category that characterized the severity of
injury: starting from 0 (no injury) to 3 (globally sclerotic glomeruli). (G) Graph of glomerular injury scores in OC. The highest percentage of
uninjured glomeruli (score 0) was in young mice (black bars). Middle age mice (gray bars) showed a significantly higher percentage of injured
glomeruli (score- 1, 2) and increase in the severity of injury (score-3). Aged mice (white bars) showed a significantly higher percentage of
injured glomeruli (score-1,2), and an increase in the severity of injury (score-3) compared to young and middle age mice, while the
percentage of uninjured glomeruli was significantly decreased in aged versus young and middle age mice. (H) Graph of glomerular injury
scores in the JMC. The percentage of injured glomeruli (score-1, 2) was significantly higher in aged mice (white bars) compared to middle age
(gray bars) and young (black bars) mice. The percentage of severely injured glomeruli (score-3) was increased but did not reach statistical
significance. Middle age mice showed a significant increase in injured (score-1,2) and severely injured glomeruli (score-3) compared young
mice. (I) Quantification of podocyte number in the OC. Podocyte number per cross section, identified by p57+ cells, showed a decreasing
trend for middle age and aged mice compared to young mice for individual injury scores, but the differences were not statistically significant.
Podocyte number was significantly lower for injured glomeruli (score-1,2,3) compared to uninjured glomeruli (score-0). (J) Quantification of
podocyte number in the JMC. Podocyte number per cross section, identified by p57+cells was higher compared to OC and showed a trend
decreasing trend for middle age and aged mice compared to young mice for individual injury scores, but the differences were not statistically
significant. Podocyte number was significantly lower for injured glomeruli (score-1,2,3) compared to uninjured glomeruli (score-0).
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Examining the differences between OC and JMC
glomeruli independently, in young 6 month-old
mice, there was only one glomerulus with migration
and differentiation (yellow cell), occurring in a
glomerulus in the JMC. This represented 0.1% of all
glomeruli, and 0.6% of all JMC glomeruli quantified. No
migration or differentiation were noted in the OC
glomeruli in young mice. In middle-aged mice, there
was a higher percentage of glomeruli with migration
(2.6%) and differentiation (0.6%), which occurred
in a greater percentage of JMC vs. OC glomeruli. Within

OC glomeruli, 2.1% had at least one migration event
and 0.4% had at least one differentiation event. JMC
glomeruli had a higher incidence of both migration
(6.7%) and differentiation (1.7%). At middle-age,
1.4% of glomeruli with at least one migration event
also had a differentiation event (20.0% in OC and 25.0%
in JMC). In aged mice, the incidence of migration
(4.0%) and differentiation (1.7%) increased over middleage for all glomeruli. In the OC, 1.9% of glomeruli
showed at least one migration event, while 0.7% of
glomeruli showed at least one differentiation

Figure 2. Migration and differentiation of tdTomato+PECs to a podocyte phenotype in aged kidneys. (A–F) Representative
confocal images of tdTomato-labeled PECs (red), EGFP+ labeled podocytes (green), and DAPI stained nuclei (blue) in young, middle age and
aged mice in OC (A–C) and JMC (D–F). Individual red (labeled with superscript-1), green (superscript-2) and far-red (superscript-3) fluorescent
channels of the glomerulus, outlined by the white dashed box. (A) Young mice (OC) showed that tdTomato+PECs are detected along
Bowman’s capsule (A1) and EGFP+ cells (A2) localized in typical podocyte distribution. Nuclei were labeled with DAPI (A3). (B) Middle age mice
(OC) showed that tdTomato+PECs (marked with solid arrow) were detected in the glomerular tuft (B1) with accompanied decrease in the
EGFP signal (B2) and the nuclear marker DAPI (B3). (C) Aged mice (OC) showed that tdTomato+PECs (marked with dashed arrow) (C1)
differentiated to a podocyte fate and co-expresses EGFP (green) (C2), overlap creates a yellow. (D) Young mice (JMC) showed that
tdTomato+PECs are detected along Bowman’s capsule (D1) and EGFP+ podocytes are observed in the glomerular tuft (D2). (E) Middle age
mice (JMC) showed that tdTomato+PECs (marked with solid arrow) are observed in the glomerular tuft (E1) with no overlap with EGFP (E2). (F)
Aged mice (JMC) showed that tdTomato+PECs (marked with dashed arrow) (F1) overlap with EGFP (F2) and create a yellow color in the
glomerular tuft. Scale bars represent 25μm or 5μm (insets).
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event. In the JMC, 17.9% showed at least one migration
event, with 7.7% having at least one differentiation
event, indicating the percentage of glomeruli with
differentiation occurring on a yes/no basis was 42.2%.
In the OC, 38.5% of glomeruli with a case of migration,
also experienced differentiation, compared with 44.7%
in JMC glomeruli.
Taken together, this data shows that with aging, there is
an increase in both the migration and differentiation

events on a per glomerulus basis. The total percentage
of involved glomeruli increases, but this increase is
disproportionally split between the OC and JMC
glomeruli, with JMC glomeruli having a much higher
percentage of involvement. However, in terms of
differentiation, despite the total percent of
differentiation on a per glomeruli basis increasing with
age, the JMC glomeruli only have a slight increase in
the percentage considered as a whole to have had a
differentiation event.

Figure 3. Quantitative analysis of migration and differentiation of tdTomato+PECs to a podocyte fate in aged kidneys. (A)
Graphs showing the migration of tdTomato⁺PECs (red cells, y-axis) plotted against the number of podocytes per glomerulus (p57+ cells, x-axis)
in young, middle age and aged mice in the OC, JMC and both compartments combined (OC and JMC). Young mice: There was no migration of
tdTomato⁺PECs in the OC, and only one event of migration of a tdTomato+PEC to the glomerular tuft in JMC. When OC and JMC were
combined, there was only the one event of migration accordingly. Middle age mice: The number of glomeruli with migration of
tdTomato+PECs increased compared to young mice. There was a higher number of glomeruli with migration in the OC compared to JMC. The
total increase in migration was reflected when OC and JMC were combined. The glomeruli with migration events tended to be higher in
glomeruli with lower podocyte numbers. Aged mice: The number of glomeruli with migration of tdTomato+PECs to the glomerular tuft was
the highest in aged mice compared to young and middle age mice. The incidence of migration predominantly increased in JMC versus OC,
and the total increase in migration was reflected when OC and JMC were combined. Again, glomeruli with migration events tended to be
higher in glomeruli with lower podocyte numbers. (B) Graphs showing the differentiation of tdTomato+PECs (yellow cells, y axis) plotted
against the number of podocytes per glomerulus (p57+ cells, x-axis) in young, middle age and aged mice in the OC, JMC and both
compartments combined (OC and JMC). Young mice: There was no differentiation of tdTomato⁺PECs (tdTomato+EGFP+) observed in the OC,
and only one event of differentiation in one glomerulus in JMC glomeruli. When OC and JMC were combined, there was only the one event of
differentiation accordingly. Middle age mice: The number of glomeruli with differentiation of tdTomato⁺PECs (tdTomato+EGFP+) increased
compared to young mice. There were slightly more glomeruli with differentiation in the OC compared to JMC. The total increase in
differentiation was relatively low and was reflected when OC and JMC were combined. The glomeruli with differentiation events tended to
be higher in glomeruli with lower podocyte numbers. Aged mice: The number of glomeruli with differentiation of tdTomato⁺PECs
(tdTomato+EGFP+) was the highest in aged mice compared to young and middle age mice. The incidence of differentiation increased in both
OC and JMC glomeruli, and the total increase was reflected when OC and JMC were combined. Again, glomeruli with differentiation events
tended to be higher in glomeruli with lower podocyte numbers.
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Aged mice have higher extracellular
accumulation along Bowman’s capsule

matrix

Co-staining with collagen IV (Col IV) was performed to
determine extracellular matrix accumulation in aged
glomeruli with PECs that differentiated towards a
podocyte fate in the OC and JMC (Figure 4). There
was an increase in collagen IV staining along
Bowman’s capsule in aged OC glomeruli with newly
generated podocytes from PEC origin compared to

young mice (Figure 4A, 4B). In aged JMC glomeruli,
the increased number of PECs that differentiated
towards a podocyte fate was accompanied by a higher
degree of collagen IV staining along Bowman’s capsule
(Figure 4C, 4D).
These findings are similar to our previous report
in a model of FSGS, where a subpopulation of
PECs that differentiated towards a podocyte fate
(TdTomato+/EGFP+ (yellow) cells) were observed along

Figure 4. Collagen IV staining increases along Bowman's capsule with accompanied migration of tdTomato+PECs in aged
mice. (A–D) Representative confocal images of tdTomato+ (red), EGFP+ (green) and Collagen IV staining (blue) in young and aged mice. The
inserts show separate channels of the outlined glomeruli, with superscripts: 1=tdTomato, 2=EGFP, 3=Collagen IV and 4=merged. (A) Young
mice (OC) showed that tdTomato+PECs are limited to Bowman’s capsule (A1) and EGFP+ podocytes to the glomerular tuft (A2). Collagen IV
staining (blue) (A3) was used to delineate the kidney architecture. (B) Aged mice (OC) showed that differentiated yellow cells
(tdTomato+PECs+ EGFP+) (marked with white arrows) were detected in the glomerular tuft (B1, B2) which was accompanied by an increase in
Collagen IV staining along BC (white arrow heads) (B3). (C) Young mice (JMC) showed that differentiated yellow cells (tdTomato+PECs+ EGFP+)
were detected in some glomeruli along Bowman’s capsule (C1, C2) which was accompanied by an increase in Collagen IV staining along BC
(white arrow heads) (C3). (D) Aged mice (JMC) showed that differentiated yellow cells (tdTomato+PECs+ EGFP+) have migrated to the
glomerular tuft (marked with white arrows) and co-express tdTomato (D1), EGFP (D2), which was accompanied by an increase in Collagen IV
staining along BC (white arrow heads) (D3). Scale bars represent 25μm or 5μm (insets).
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Bowman’s capsule in about 30.0% of young glomeruli
[24]. In this study, aged mice showed a slightly higher
percentage of glomeruli with differentiated PECs along
Bowman’s capsule (40.0±7.0%). Previously, we
described these cells as “parietal podocytes” or
“transitional PECs” [32–35] and showed that they move
to the glomerular tuft during FSGS [24], which we
confirmed in this model of aging.

Phenotypic and ultrastructural confirmation that a
subset of PECs differentiate to a podocyte fate
To prove that a subset of labeled PECs that migrated to
the glomerular tuft acquired podocyte-like features,
immunofluorescence staining was performed for
podocin (Figure 5) and nephrin (Figure 6). Antibodies
were not required for detection of tdTomato reporter-

Figure 5. A subset of newly generated podocytes (tdTomato+EGFP+) from PEC origin co-express podocin in the glomerular
tuft of aged mice. (A–D) Representative confocal images of tdTomato+ (red), EGFP+ (green) and podocin staining (blue) in young and aged
mice. The inserts show separate channels of the outlined glomeruli, with superscripts: 1=tdTomato, 2=EGFP, 3=podocin and 4=merged.
Podocin staining was detected with an antibody, tdTomato and EGFP reporters were detected without antibody. (A) Young mice (OC) showed
that tdTomato+PECs (red) are detected along Bowman’s capsule (A1). The majority of EGFP+ cells (green) (A2) co-localize with podocin (blue)
(A3) and create a cyan color (A4). (B) Aged mice (OC) showed that a subset of differentiated tdTomato+ PECs (red) (B1) co-expresses EGFP+
(green) (B2) and podocin (blue) (B3) creating a pink/white color in the glomerular tuft (white arrows) (B4). (C) Young mice (JMC) showed that
tdTomato+PECs (red) (C1) are detected along Bowman’s capsule. The majority of EGFP+ cells (green) (C2) co-localize with podocin (blue) (C3) in
the glomerular tuft creating a cyan color (C4). (D) Aged mice (JMC) showed that a higher number of tdTomato+PECs (red) (D1) have migrated
to the glomerular tuft (marked with white arrows), become EGFP+ (D2) and co-localized with podocin (blue) (D3), creating a pink/white color
(D4). Scale bars represent 25μm or 5μm (insets).
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labeled PECs and EGFP reporter-labeled podocytes.
There was no overlap between the three colors in young
mice in OC and JMC glomeruli. In contrast, cells with a
white/purple color, representing the merge of red
(tdTomato), green (EGFP) and blue (used for podocin
and nephrin) were detected in a subset of both OC and
JMC glomeruli of aged mice. In contrast, podocytes
derived from PECs (yellow cells) did not co-express
Perlecan (Supplementary Figure 3), used as a mesangial
cell marker, nor CD31, used as an endothelial cell
marker (Supplementary Figure 4).

Immunofluorescence staining with anti-RFP (tdTomato
PEC reporter) and anti-EGFP (podocyte reporter) on
paraffin embedded kidney sections from young, middle
age and aged mice, with sequential peroxidase staining,
detecting p57 staining on the same sections, showed that
the majority of p57+ cells were EGFP labeled in young
mice (Supplementary Figure 2A and 2B). A subpopulation
of anti-RFP labeled cells (tdTomato+ PECs) observed in
the glomerular tuft of middle age mice were p57-positive.
(Supplementary Figure 2C, 2D) Newly generated
podocytes from PEC origin observed in glomeruli of aged

Figure 6. A subset of newly generated podocytes from PEC origin (tdTomato+EGFP+) co-express nephrin in the glomerular
tuft of aged mice. (A–D) Representative confocal images of tdTomato staining (red fluorescent protein, RFP) (red), EGFP+ (green) and
nephrin staining (blue) in young and aged mice. The inserts show separate channels of the outlined glomeruli, with superscripts: 1=tdTomato,
2=EGFP, 3=nephrin and 4=merged. (A) Young mice (OC) showed that tdTomato+PECs (red) were observed along Bowman’s capsule (A1) and
genetically labeled podocytes (EGFP+ cells, green) (A2) co-express nephrin (blue) (A3), creating a cyan color (A4). (B) Aged mice (OC) showed
that a subset of tdTomato+ PECs (labeled with red fluorescent anti-RFP) (B1) co-expresses EGFP+ (green) (B2) and nephrin (blue) (B3) creating a
pink/yellow color in glomerular tuft (marked with white arrow) (B4). (C) Young mice (JMC) showed that tdTomato+ staining PECs were
observed along Bowman’s capsule (C1) EGFP staining (C2) was detected in a typical podocyte distribution and overlaps with nephrin staining
(C3), creating a cyan color (C4). (D) Aged mice (JMC) showed that tdTomato+ staining PECs (D1) (marked with white arrows) have migrated
onto the glomerular tuft and differentiated to a podocyte fate, co-staining with EGFP (green) (D2) and nephrin (blue) (D3) creating pink/yellow
color (D4). Scale bars represent 25μm or 5μm (insets).
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mice were anti-RFP-positive, anti-EGFP-positive and p57positive (Supplementary Figure 2E, 2F).
Finally, expansion microscopy was performed to define
ultrastructure (Figure 7). Single channels show that the
green cell (Figure 7A1 and 7B1) on the glomerular tuft
was derived from PEC origin (red color) (Figure 7A2
and 7B2) to create a yellow color with major, primary
and secondary foot processes (Figure 7C). Figures 7D,
E and F show consecutive z-stacks through the newly
generated podocyte and higher magnified images show
tertiary foot processes (Figure 7D1, 7E1, 7F1).

Taken together, in individual glomeruli typified by
podocyte depletion, a subset of cells of PEC origin
migrate to the glomerular tuft and de novo express three
podocyte proteins, and acquire ultrastructural features
characteristic of podocytes.
Podocyte-like cells derived from PECs express de
novo VEGF-A
Within the glomerulus, VEGF is considered podocytederived [24, 36–38]. Figure 8 shows VEGF-A staining
localized to podocytes in young mice (Figure 8A

Figure 7. Ultrastructure of newly generated podocytes from PEC origin (tdTomato+EGFP+) in the glomerular tuft of aged mice.
(A) Representative confocal image of expansion microscopy of a glomerulus in an aged mouse with a newly generated podocyte from PEC
origin (marked with dashed box). Superscripts show separate channels: tdTomato+ (red) (A1) and EGFP+ (A2). (B) Higher magnification of
image shown in A of newly generated podocyte, with accompanied single color images of tdTomato (B1) and EGFP (B2). (C) The newly
generated podocyte has classic podocyte architecture: a cell body (labeled with red circle), primary process (red triangle), several secondary
processes (red rhombuses), branching to minor and tertiary foot processes (C1–C3 labeled with dashed boxes). (D–F) Higher magnification of
images shown in dashed boxes C1–C3 with different z-stack focal planes show various tertiary foot processes (labeled with red arrows). Scale
bars represent 25μm or 5 μm (inset) and are in pre-expansion dimensions.
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and 8C). In aged mice, a subset of newly generated
podocytes derived from PECs express VEGF-A, creating
a white/yellow color, in both OC and JMC glomeruli
(Figure 8B and 8D). This suggests that these cells acquire
one of the synthetic functions typified by podocytes.
Subpopulations of migrated PECs co-express CD44,
but newly generated podocytes from PEC origin do
not express PEC the marker PAX8 and do not
proliferate in the glomerular tuft of aged mice
CD44 is a marker of PEC activation, defined as a profibrotic and migratory phenotype, and increases in aged

PECs [3, 19, 39]. However, it is also a marker for
progenitors in certain non-kidney cells [40–42]. CD44
was not detected in the glomeruli of young mice (Figure
9A). However, CD44 was detected in a subset of PECs
along Bowman’s capsule and PECs that migrated to the
glomerular tuft (Figure 9B).
PECs were identified by PAX8+ staining and the
majority of tdTomato+ cells co-localized with PAX8
along Bowman’s capsule of young mice (Figure 9C).
However, newly generated podocytes from PEC origin
do not express PAX8 in the glomerular tuft in aged
mice (Figure 9D).

Figure 8. A subset of newly generated podocytes from PEC origin (tdTomato+EGFP+) de novo express VEGF-A in the
glomerular tuft of aged mice. (A–D) Representative confocal images of tdTomato+ (red), EGFP+ (green) and VEGF-A (blue, podocyte
specific marker) in young and aged mice. The inserts show separate channels of the outlined glomeruli, with superscripts: 1=tdTomato,
2=EGFP, 3=VEGF-A and 4=merged. (A) Young mice (OC) showed that tdTomato+PECs were observed along Bowman’s capsule (A1). EGFP
reporter (A2) overlaps with VEGF-A staining (A3) and creates a cyan color (A4). (B) Aged mice (OC) showed that a subset of differentiated
tdTomato+ PECs (red) (B1) co-expresses EGFP+ (green) (B2) and VEGF-A (blue) (B3) creating a yellow/white color in the glomerular tuft (white
arrows) (B4). (C) Young mice (JMC) showed that tdTomato+ staining PECs were observed along Bowman’s capsule (C1) EGFP staining (C2) was
detected in a typical podocyte distribution and overlaps with VEGF-A staining (C3), creating a cyan color (C4). (D) Aged mice (JMC) showed
that tdTomato+ staining PECs (D1) (marked with white arrows) have migrated onto the glomerular tuft and differentiated to a podocyte fate,
co-staining with EGFP (green) (D2) and VEGF-A (blue) (D3) creating pink/yellow color (D4). Scale bars represent 25μm or 5μm (insets).
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In order to measure proliferation in aged mice, staining
for Ki67 was used [43]. Ki67+ cells were detected in the
interstitium in young mice (OC and JMC)
(Supplementary Figure 5A, 5C). Likewise, occasional
tubular cells expressed Ki67 in the OC compartment in
aged mice (Supplementary Figure 5B). A subpopulation
of PECs expressed Ki67 in aged JMC glomeruli, but did
not express EGFP (Supplementary Figure 5D). These
results indicate, that a subset of activated PECs migrate
to glomerular tuft but newly generated podocytes from
PEC origin do not express PAX8 and do not proliferate
in aged glomeruli.

DISCUSSION
Healthy aging is accompanied by changes to the kidney,
including a progressive decline in podocyte number and
density [5, 22]. Because terminally differentiated
podocytes are unable to self-renew, any replacement has
to derive from another cell source, namely a podocyte
progenitor [9, 44]. In the current study, we used a
genetic approach in a dual PEC-PODO reporter mouse
[24] to ask if glomerular parietal epithelial cells (PECs)
can indeed differentiate to a podocyte fate as podocyte
number progressively declines with advancing age. Our

Figure 9. The majority of tdTomato+PECs co-express PAX8 along Bowman’s capsule, however newly generated podocytes
from PEC origin no longer express PAX8. Activated PECs (tdTomato+CD44+) were detected in the glomerular tuft of aged
mice. (A, B) Representative confocal images of tdTomato+ (red), EGFP+ (green) and CD44+ (blue) in young and aged mice. The inserts show
separate channels of the outlined glomeruli, with superscripts: 1=tdTomato, 2=EGFP, 3=CD44 and 4=merged. (A) Young mice showed that
CD44 staining was not detected in the glomerular tuft. An occasional CD44+ cell was observed around glomeruli (marked with arrow heads).
Each channel for the glomerular tuft region marked with the dashed box are presented in panels (A1–A4). (B) Aged mice showed that a
subpopulation of tdTomato+PECs (B1) that migrated to glomerular tuft were positive for CD44 (magenta color, B3- B4), marked with dashed
arrows, with no overlap with EGFP (B2). (C, D) Representative confocal images of tdTomato+ (red), EGFP+ (green) and PAX8 (blue) in young
and aged mice. The inserts show separate channels of the outlined glomeruli, with superscripts: 1=tdTomato, 2=EGFP, 3=PAX8 and
4=merged. (C) Young mice showed that PAX8 staining (C3) was detected in PECs along Bowman’s capsule and co-localized with tdTomato
reporter (C1) creating a pink/purple color (C4) (marked with white arrows). PAX8 was not detected in podocytes (EGFP+ cells) (C2). (D) Aged
mice showed that the majority of tdTomato+PECs (D1) co-express PAX8 (D3) creating a magenta/white color (D4) (marked with solid arrow).
However, newly generated podocytes from PEC origin (tdTomato+EGFP+) (D1, D2) do not express PAX8 in the glomerular tuft of aged mice
(marked with arrow heads). Scale bars represent 25μm or 5μm (insets).
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results show that in glomeruli in which podocyte
number declines below a certain threshold, a subset of
PECs migrate to the glomerular tuft, where they de
novo express podocyte markers, make VEGF-A and
acquire podocyte ultrastructural features.
The regeneration of podocytes is an active area of
study, because when these terminally differentiated
epithelial cells decrease in number in disease, or in
healthy aging, they are unable to proliferate, and thus
cannot self-renew. Reduced podocyte number
underlies glomerular scarring [45]. Thus, any
replacement of “lost” podocytes must derive from
another cell source. PECs have been considered a
progenitor source for both adolescent podocytes
during normal kidney maturation [46], and adult
podocytes in disease [10–12]. However, some studies
in adult mice have refuted this notion [18, 46].
Several considerations might underlie the differences
in results, including mouse species, the use of reporter
labeling, the cell specific gene used for reporting,
mouse sex and age, the type of experimental animal
models used, methodologies used to assess podocyte
number, and others.
Why is the methodology to measure podocyte number
important in this debate? [47–49] Methods that rely on
the podocyte mean derived by summing podocyte
number (numerator) in a fixed number of glomeruli
(denominator) regardless of their degree of injury, will
underestimate podocyte replacement in individual
glomeruli because of the focal nature of disease in
healthy aging. In the current study, we make two
important observations in this context. First, we noted
that in healthy glomeruli (defined as no injury on PAS or
silver staining) of middle-aged and aged mice, podocyte
number was typically normal. In contrast, with increasing
glomerular injury with advancing age, podocyte number
decreased in those individual glomeruli with injury
scores of 1, 2 and 3. Second, within individual glomeruli
with a normal podocyte number per glomerular cross
section, no labeled PECs migrated to the tuft. This makes
sense from a regeneration viewpoint, as there is no
demand for regeneration in the setting of a normal
podocyte number. However, within individual glomeruli,
there is a threshold of podocyte number (less than 10 per
glomerular cross section) that correlates with the
migration of (red) PECs to the tuft, and a second
threshold that accompanies the subsequent differentiation
of PECs to a podocyte fate (less than 7 per glomerular
cross section), evidenced by a yellow color (Figure 3).
Moreover, as podocyte number decreases further in
individual glomeruli, both PEC migration to the
glomerular tuft and differentiation to a podocyte fate
increases. There is no differentiation in glomeruli with a
normal podocyte number, because there is no need.
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This is significant, because although the overall
percentage of glomerular cross sections with red and
yellow cells was only 4.1% and 1.7% respectively, in
terms of accessing possible repair, we should consider
glomeruli where repair is warranted, because a
glomerulus with a healthy podocyte population would
have no need for replacement of cells. In glomeruli with
podocyte loss that was great enough to warrant
migration (red cells on the tuft), 41.0% of those
glomeruli experienced differentiation to a podocyte fate,
defined by the presence of a yellow cell. The majority
of yellow cells had phenotypic features of podocytes
(see below).
We recognize that a potential pitfall of this analysis is
only considering glomerular cross sections that are 4μm
thick, in the context that glomeruli are ~ 70 μm in
diameter. Moreover, the area of the tuft was not taken
into consideration when assessing p57. If one assumes
that a glomerular tuft is a sphere with equally
distributed podocytes, the best-case scenario of a slice
through the exact center, we are sampling only 8.6% of
each glomerulus. However, despite this relatively small
sampling per glomerulus, and the fact that PEC number
decreases with advancing age, observing events of
migration and differentiation suggest they are actually
not rare events, and are plausibly biologically relevant.
Another pitfall in the underestimation of migration and
differentiation of PECs is that the overall PEC number
decreases with advancing age [19, 20]. That said, the
combination of reduced PEC progenitor number with
age, and many of the remaining PECs undergoing
changes such as to a myofibroblast phenotype, reduce
the biological plausibility that robust differentiation of
PECs to a podocyte fate decreases progressively with
advancing age, and therefore may not be adequate for
full regeneration and repair.
We acknowledge weaknesses in these studies. First, we
have not accounted for changes to the immune system
with aging, both locally in the kidney, and systemically.
Second, mouse strain might influence outcomes. Third,
sex differences need to be better understood as a
potential confounder for podocyte regeneration. Finally,
we have not determined if any pharmacological
interventions could either enhance podocyte
regeneration in aged mice, or even prevent age-related
changes to podocytes. That said, we have previously
reported that PEC number is higher in aged mice given
the mitochondrial stabilizer SS-31 [3] or the mTOR
regulator rapamycin [39], raising the possibility that in
doing so, the reservoir of PEC progenitors is increased.
Further studies are needed in aged dual PEC-Podo mice.
The following results support the notion that a subset of
PECs do indeed differentiate to a podocyte fate in aged
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glomeruli: yellow cells acquire de novo expression of
podocin, nephrin, p57 and VEGF-A, and change
morphology to a cell with primary, secondary and
tertiary processes. These cells do not express CD44,
which reinforces the paradigm that when CD44 is
increased in PECs, this is not a regenerative transition,
but rather one that likely reduces their capacity to
differentiate to a podocyte fate.

and constitutive EGFP expression in podocytes. Control
mice comprised of quadruple transgenic mice without
the rtTA or FLPo. Mice were housed in the animal care
facility of the University of Washington under specific
pathogen-free conditions. Studies were reviewed and
approved by the University of Washington Institutional
Animal Care and Use Committee (2968-04).
Reporter induction

We have previously reported that with advancing age,
glomeruli in the juxta-medullary portion of the cortex
are more severely injured than those in the outer cortex
[3, 19, 20]. Accordingly, we asked if the region of
glomeruli within the kidney impacts PEC differentiation
to a podocyte fate, by examining individual OC and
JMC glomeruli. The results show that, the percentage of
differentiation occurring on a yes/no basis per
glomerulus was 38.5% in OC glomeruli and 44.7% in
JMC glomeruli.

Finally, one should ask if the replacement of
podocytes in individual glomeruli by PEC progenitors
is sufficient in the aged kidney? While podocyte
replacement clearly derives from PEC origin in a
subset of glomeruli, this is not a universal
phenomenon. Overall, podocyte number is lower in
healthy aged mice than in healthy young and middleaged mice. Taken together, we conclude from the data
in this study that the capacity for PEC progenitors to
transition to a podocyte fate is reduced with aging,
compared to younger mice. We speculate that this is
multi-factorial, including a decrease in the number of
PEC progenitors and changes to their phenotype from
an epithelial state to a myofibroblast-like state.

MATERIALS AND METHODS
Animals
Dual
reporting
PEC-rtTA|LC1|tdTomato|Nphs1FLPo|FRT-EGFP (named PEC-PODO mice in this
manuscript) were bred by first crossing previously
reported PEC-reporter mice [15, 46, 50, 51], with the
tdTomato clone Ai14 mouse (The Jackson Laboratory
Stock #007914) [52] to replace the original Rosa26
(LacZ) reporter. These PEC|tdTomato reporter mice
were then crossed with our previously generated Nphs1FLPo|FRT-EGFP mouse. The Nphs1-FLPo|FRT-EGFP
mouse expresses FLP recombinase as previously
described by Goldberg et. al. [53], resulting in the FLP
mediated excision of an FRT flanked STOP in the
RCE:FRT [54] (JAX Stock#: 010812) mouse available
from The Jackson Laboratory (Bar Harbor, ME).
Resulting animals have conditional tdTomato
expressing PECs upon administration of doxycycline,
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Adult mice (10-12 weeks of age) were fed ad libitum
625mg/kg Doxycycline Chow (TD.01306, Envigo,
Indianapolis, IN) for 3 weeks to induce permanent
labeling of PECs with tdTomato reporter. Animals were
otherwise provided standard housing, ad libitum food
and water. No drugs were required for the induction of
the EGFP reporter.
Tissue collection
Male and female mice were randomly divided into two
cohorts. One cohort was terminally sacrificed at 6
months of age (young), while the second were
designated for aging. Animals designated for aging
underwent survival biopsies at 14 months of age
(middle age) as previously reported [20] under aseptic
conditions as approved by the University of Washington
Institutional Animal Care and Use Committee. For
terminal kidney necropsies at 6 months of age (n=9) or
20-24 months of age (aged, n=14), mice were killed
with an overdose of Ketamine (JHP Pharmaceuticals
LLC, Rochester, MI)/Xylazine (Patterson Veterinary,
Devens, MA)as previously described [27]. Kidney
tissue was butterflied and one half butterfly was placed
into 4% paraformaldehyde (PFA, Affymetrix, Santa
Clara, CA) in PBS for 45 minutes, washed briefly in
PBS, placed in 30% sucrose (Sigma-Aldrich, St Louis,
MO) in PBS overnight, blotted dry, embedded in
Tissue-Tek® O.C.T. Compound (VWR, Radnor, PA),
and frozen in a 100% ethanol/dry ice bath. The second
half of the butterflies were placed into 10% neutral
buffered formalin (NBF) (Globe Scientific, Mahwah,
NJ) overnight at 4°C, transferred to 70% ethanol, and
embedded in paraffin.
Assessment of Glomerulosclerosis and Podocyte
Depletion
Immunostaining was performed for p57 with PAS
counterstaining to measure podocyte density and assess
glomerulosclerosis, as previously reported [34, 48, 55,
56]. In brief, paraffin sections were de-paraffinized and
rehydrated. Antigen retrieval was performed by
microwave heating in 1 mM EDTA, pH 8.0 for 10 min.
The following solutions were applied for blocking: 3%
hydrogen peroxide for 20 minutes and freshly made 5%
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nonfat dry milk for 30 minutes. Secondary horseradish
peroxidase conjugated antibodies were detected with
diaminobenzidine
(DAB,
Sigma-Aldrich).
Counterstaining was performed with periodic-acid
Schiff and hematoxylin as previously described [39].
Slides were dehydrated in ethanol and mounted with
Histomount (National Diagnostics, Atlanta, GA).
Kidney cortex was divided in two compartments: outer
cortex (OC) and juxta-medullary cortex (JMC) as
previously described [3, 20]. An average of 45±10
glomeruli from the OC and 20±5 glomeruli from the
JMC were quantified for each mouse. Every captured
glomerulus was ranked on a scale of 0-3 to determine
glomerulosclerosis as previously described [3]. In brief:
0 = no injury, 1 = one third of the glomerular tuft crosssection showed mesangial and limited or partial
Bowman’s capsule thickening; 2 = greater than 50% of
the glomerular tuft showed mesangial and Bowman’s
capsule thickening, loss of podocytes and capillary loop
structure; 3 = entirely sclerotic glomerulus. For each
compartment (OC and JMC) the total mean score was
calculated as previously described [3].
Assessment of glomerular scarring and extracellular
matrix
Jones’ basement membrane staining was performed by
the University of Washington Pathology Research
Services Laboratory on tissue embedded in paraffin
from young, middle age and aged mice in order to
determine extracellular matrix accumulation.
Multicolor immunofluorescence staining

Multicolor immunofluorescence
peroxidase staining

Immunostaining was performed on 4μm sections from
frozen and formalin fixed paraffin-embedded (FFPE)
tissue as previously described [57]. Briefly, frozen
sections were allowed to air-dry and OCT compound
was removed in PBS (pH 7.4). Paraffin sections were
deparaffinized and blocked for biotin (Vector Labs,
Burlingame, CA). Background buster (Accurate
Chemical & Scientific, Westbury, NY) was used to
block non-specific antibody binding. The appropriate
biotinylated secondary antibody (Vector Laboratories)
was applied followed by Streptavidin, AlexaFluor 647
conjugate (Life Technologies - Molecular Probes,
Grand Island, NY). All immunofluorescence samples
were mounted using Vectashield with DAPI (Vector
Labs, Burlingame, CA). As a negative control, staining
was performed without primary antibody.
Primary
antibodies
immunofluorescence

and

conditions

for

In order to visualize tdTomato and EGFP on FFPE
samples, the following antibodies were applied: DyLite
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594 conjugated red fluorescent protein antibody (1:100,
Rockland Inc. Limerick, PA), that specifically detects
the tdTomato reporter and anti-EGFP green fluorescent
protein (1:100, Clontech, Mountain View, CA). To
identify podocytes, the following antibodies were used:
anti-podocin (1:4,000, Abcam, ab50339, Cambridge,
MA), anti-nephrin (1:500, Fitzgerald Industries
International. Inc., Concord, MA) and anti-p57 (1:500,
Santa Cruz Biotechnology, Dallas, TX). To outline the
kidney architecture, biotinylated collagen IV antibody
(1:100, Southern Biotechnology, 1340-08, Birmingham,
AL) was applied overnight. Kidney endothelial cells
were marked by a CD31 antibody (1:100, Abcam,
Cambridge, MA). “Activated” PECs were marked by
staining with a CD44 antibody (1:50, Clone IM7, BD
Biosciences, San Jose, CA). Mesangial cells were
identified by using a Perlecan antibody (gift from Jeff
Miner). To determine vascular growth factor
expression, which is highly expressed in podocytes [24,
36–38], staining with VEGF-A antibody (1:200,
Abcam, ab 52917, Cambridge, MA) was performed
overnight. To identify parietal epithelial cells (PECs)
immunostaining with a Pax8 antibody (1:500, Protein
Tech Group, Chicago, IL) was performed overnight. To
detect proliferation in aged dual reporter mice, a Ki67
[43] antibody was used (1:100, Thermo Fisher
Scientific, Waltham, MA, USA). The appropriate
biotinylated secondary antibody (1:400, Vector
Laboratories, Burlingame, CA) was applied, followed
by Streptavidin AlexaFluor 647 conjugate (1:200, Life
Technologies - Molecular Probes, Grand Island, NY).
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by

sequential

Paraffin sections were deparaffinized and rehydrated.
Antigen retrieval was performed by microwave heating
in 1 mM EDTA, pH 6.0 for 10 min. The following
solutions were applied for blocking: Avidin/Biotin
solutions (Vector Laboratories, Burlingame, CA) for 20
minutes and background buster (Accurate Chemical &
Scientific, Westbury, NY) for 30 minutes. The
following primary antibodies were applied overnight to
detect the reporters: Anti-RFP (tdTomato reporter)
(1:100, Rockland Inc. Limerick, PA) and anti-EGFP
(podocyte specific reporter) (1:100, Clontech, Mountain
View, CA). This was followed by the appropriate
biotinylated secondary antibody (Vector Laboratories,
Burlingame, CA) and then by Streptavidin, AlexaFluor
488 conjugate (1:200, Life Technologies - Molecular
Probes, Grand Island, NY). Slides were mounted with
Vectashield/DAPI
mounting
media
(Vector
Laboratories, Burlingame, CA). Fluorescent images
were collected at 400x magnification. Coverslips were
gently removed by soaking slides in PBS, and slides
were subsequently stained for p57/PAS as described
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above. Brightfield images were collected and combined
with immunofluorescent images, showing the same
glomeruli in both sets of images.

performed by incubating kidney slices in DI water for
30 min with 1–2 exchanges. Poly-L-lysine-coated
coverslips were used for mounting. Imaging was then
immediately performed on the samples.

Quantiﬁcation of migrated PECs to glomerular tuft
Microscopy
Migrated PECs were identified as cells expressing
TdTomato+ or TdTomato+ / EGFP+ reporters in the
glomerular tuft area. Young mice: An average of 1115
glomeruli were sampled, of which 951 (85.3%) were
OC glomeruli and 164 (14.7%) were JMC glomeruli.
Middle aged: An average of 533 glomeruli were
sampled, comprising 473 (88.7%) in the OC and 60
(11.2%) in the JMC. Aged mice: An average of 1605
glomeruli were sampled, of which 1384 (86.2%) were
OC and 221 (13.8%) were JMC glomeruli respectively.
Quantification of podocytes in glomeruli with PECs
migrated to the glomerular tuft
Three color staining for p57 and the RFP and EGFP
reporters was performed, and the number of p57+ cells
in the OC and JMC were measured for each animal.
Data were expressed as the average number of p57+
cells per kidney cross section.
Expansion of a kidney specimen using ExM
Expansion microscopy was performed by using a
previously described protocol [58]. Dual reporting PECPODO mice (n=2) were sacrificed at 20-24 months of
age as described above. Murine kidneys were fixed with
4% paraformaldehyde (PFA, Affymetrix, Santa Clara,
CA) in PBS for 45 minutes and incubated overnight in
30% sucrose (Sigma-Aldrich, St Louis, MO) in PBS.
They were then washed with PBS and cut into 60 µm
thick slices. The slices were incubated with MA-NHS in
PBS for 1 hour at room temperature followed by three
washes with PBS. Gelation solution was prepared by
mixing: monomer solution (1× PBS, 2 M NaCl, 2.5%
(wt/wt)
acrylamide,
0.15%
(wt/wt)
N,N′methylenebisacrylamide, 8.625% (wt/wt) sodium
acrylate) and was applied for 1 hour at 4 °C, followed
by incubation with monomer 0.01% (wt/wt) TEMPO
solution (45 minutes). Lastly, TEMPO in monomer
solution to final concentration of 0.2% (wt/wt) with
ammonium persulfate (APS) added was immediately
applied to the tissue, and a coverslip was placed on top.
Tissues were allowed to gel at 37 °C for 1.5–2.5 h. in a
humidified chamber. Tissue digestion was performed
overnight at 37 °C with proteinase K digestion buffer
(1× TAE buffer, 0.5% Triton X-100, 0.8 M guanidine
HCl, 8 units mL−1 proteinase K), followed by washing
with PBS. Next, kidneys were digested in collagenase
buffer (1× HBSS, 0.7 mM CaCl2, 5 mg mL−1
collagenase) overnight at 37 °C. Tissue expansion was
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Two–dimensional images were detected on a Leica TCS
SPE II laser scanning confocal microscope (Leica,
Wetzlar, Germany) using 400x magnification and an
EVOS FL Cell imaging system (Thermo Fisher
Scientific, Waltham, MA, USA) using 200x
magnification.
Statistical analysis
Data are shown as the mean ± S.E.M. Student’s t-test
was applied for comparisons between groups. Multiple
groups were compared using one-way ANOVA with
post hoc Tukey HSD test. P values <0.05 represented
statistically significant differences.

Abbreviations
EGFP: enhanced green fluorescent protein; FSGS: focal
segmental
glomerulosclerosis;
PODO:
Nphs1FLPo/FRT-EGFP podocyte reporter; SSR: site specific
recombinase; tdTomato: tdTomato (red) fluorescent
protein; PEC: glomerular parietal epithelial cell; OC:
outer cortex; JMC: juxta-medullary cortex.
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SUPPLEMENTARY MATERIALS
Supplementary Figures

Supplementary Figure 1. Glomerular scarring and extracellular matrix accumulation in basement membrane was higher in
aged mice. (A–F) Representative images taken at 20x of Jones’ (Silver) staining in young (A, B), middle age (C, D) and aged mice (E, F).
Glomeruli were divided into outer cortex (OC) (A, C, E) and juxta-medullary cortex (JMC) (B, D, F) compartments. Small inserts (40x) represent
examples of glomeruli from each group, (A1, B1)-young mice, (C1, D1)-middle age glomeruli (OC and JMC) with increased thickness of BC (E1)OC aged glomeruli with segmental sclerosis and increased thickness of BC, (F1)- JMC aged glomeruli with severe sclerosis and increased
thickness of BC.
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Supplementary Figure 2. Lower podocyte number was accompanied by a decrease in the podocyte specific EGFP reporter,
and increased migration and differentiation of tdTomato+PECs to a podocyte fate in aged kidneys. (A–F) Paraffin embedded
kidney sections from young, middle age and aged groups of mice were stained for podocyte marker p57 with PAS counterstain (A, C, E) and
imaged. Subsequently, the same sections were stained for RFP (tdTomato reporter) and EGFP (podocyte reporter) (B, D, F). Small inserts
show individual channels (1-red, 2-greeen, 3-far red) and merge of the area outlined by the white dashed boxes. (A, B) Young mice showed
typical distribution of p57 stained nuclei (marked with red arrows) (A) Immunofluorescent image of the same glomerulus showed that
majority of p57+ cells co-express EGFP reporter (B, B2, B4) (marked with white arrows), RFP-labeled PECs localized along BC (B, B1, B4), nuclei
labeled with DAPI (B, B3, B4). (C, D) Middle age mice showed that decrease in P57+ podocytes (C) (marked with red arrows) accompanied a
decrease in EGFP (D, D2, D4) (marked with white arrows). This was accompanied by migration of RFP labeled PECs (D, D1, D4) to the
glomerular tuft (marked with arrow head) and segmental decrease in DAPI staining (D, D3, D4). (E, F) Aged mice showed that decrease in p57+
cells (E) (marked with dashed red arrows) accompanied a decrease in EGFP. This was also accompanied by migration of RFP labeled PECs (F,
F2, F4) (marked with white dashed arrows) to the glomerular tuft and expression of EGFP, suggesting that migrated tdTomato+PECs
differentiate towards podocyte phenotype in aged kidneys. Scale bars represent 25μm or 5μm (insets).
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Supplementary Figure 3. Newly generated podocytes from PEC origin (tdTomato+EGFP+) are not mesangial cells. (A–D) Frozen
kidney samples from young and aged groups of mice are stained for mesangial cell marker Perlecan (blue). Permanently labeled PECs
(tdTomato reporter) and EGFP reporter are detected without the use of an antibody. Small inserts show individual channels (1-red, 2-greeen,
3-far red) and merge of the area outlined by the white dashed boxes. (A) Young mice (OC) showed that Perlecan (A3) is expressed in
mesangial cells, and is not detected in tdTomato+PECs (A1) or podocytes (EGFP+ cells) (A2). (B) Aged mice (OC) showed that Perlecan (B3) is
not detected in migrated and differentiated yellow tdTomato+EGFP+ cells (B1, B2) in the glomerular tuft (marked with solid arrow). (C) Young
mice (JMC) showed that Perlecan staining (C3) is limited to mesangial cells with no overlap with tdTomato+PECs (C1), or podocytes (EGFP+
cells) (C2). (D) Aged mice (JMC) showed that the intensity of Perlecan staining (D3) decreased in the glomerular tuft, but with no expression in
yellow tdTomato+EGFP+ cells (marked with solid arrows) (D1, D2). Scale bars represent 25μm or 5μm (insets).
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Supplementary Figure 4. Newly generated podocytes from PEC origin (tdTomato+EGFP+) are not endothelial cells. (A–D)
Representative confocal images of tdTomato (red), EGFP+ (green), and CD31 (blue) in young and aged mice. Small inserts show individual
channels (1-red, 2-greeen, 3-far red) and merge of the area outlined by the white dashed boxes. (A) Young mice (OC) showed that CD31 (A3)
staining is limited to endothelial cells, and is not detected in tdTomato+PECs (A1) or podocytes (EGFP+ cells) (A2). (B) Aged mice (OC) showed
that CD31 (B3) is not detected in migrated yellow tdTomato+EGFP+ cells (B1, B2) in the glomerular tuft (marked with white arrow). (C) Young
mice (JMC) showed that CD31 staining (C3) is detected in a typical endothelial distribution and does not show overlap with tdTomato+PECs
(C1), or podocytes (EGFP+ cells) (C2). (D) Aged mice (JMC) showed that migrated yellow tdTomato+EGFP+ cells (D1, D2) do not co-express the
endothelial marker CD31 (D3) in the glomerular tuft (marked with white arrow). Scale bars represent 25μm or 5μm (insets).
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Supplementary Figure 5. Migrated tdTomato+PECs do not proliferate in the glomerular tuft of aged mice Representative
images of tdTomato (red, Pec reporter), EGFP (green, podocyte reporter), and Ki67 (far-red, proliferation marker). Small
inserts show individual channels (1-red, 2-greeen, 3-far red) and merge of the area outlined by the white dashed boxes. (A) Young mice (OC)
showed that occasional Ki67+ cells (A3) were observed in the tubular compartment (labeled with solid arrows). tdTomato+PECs (A1) and
EGFP+ podocytes (A2) and do not co-express Ki67 in the glomerular tuft. (B) Aged mice (OC) showed that double positive tdTomato+EGFP+
cells (B1, B2) do not overlap with Ki67 (B3) in the glomerulus. Occasional tubular cells stained with Ki67+ (marked with white arrow). (C) Young
mice (JMC) showed that Ki67 staining (C3) was detected in tubular cells (marked with white arrows). EGFP+ podocytes (A2) and
tdTomato+PECs (C1) do not co-express Ki67 in the glomerular tuft. (D) Aged mice (JMC) showed that Ki67 (D3) was occasionally expressed in
tdTomato+PECs (marked with dashed arrow) along BC, tdTomato+PECs that migrated to the glomerular tuft (D1) and EGFP+ podocytes (D2)
did not overlap with Ki67. Scale bars represent 25μm or 5μm (insets).
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